Want to join the conversation?
As of 3Q15-end $DUK had 150 asserted claims for non-malignant cases with the cumulative relief sought of up to $37MM, and 63 asserted claims for malignant cases with the cumulative relief sought of up to $9MM. $DUK Carolinas expects that the ultimate resolution of most of these claims likely will be less than the amount claimed.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.